Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner
Xiaoqing Wang(Roche (China)), Rongde Wu(Shandong University), Lijuan Zhang(Nanjing University of Chinese Medicine), Wei Liu(Northeast Normal University), Liu Yang(Guilin Medical University), Mingyu Cui(Shandong University), Feng Guo(Shandong Provincial Hospital), Yongfei Zhang(Qilu Hospital of Shandong University), Shuai Liu(Tongji University)
Cited by 16
Related Papers
Characterization of ferroptosis in murine models of hemochromatosis
|Hepatology|2017|669
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute
|Nature Protocols|2019|485
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
|Cancer Discovery|2021|286